Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List Apixaban Impurity 51

Apixaban Impurity 51 synthesis

5synthesis methods
545445-44-1 Synthesis
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one

545445-44-1
435 suppliers
$7.00/1g

Acetic acid, 2-chloro-2-[2-[4-(phenylmethoxy)phenyl]hydrazinylidene]-, ethyl ester, (2Z)-

1620494-28-1
1 suppliers
inquiry

Apixaban Impurity 51

1620494-29-2
18 suppliers
inquiry

-

Yield:1620494-29-2 54 mg

Reaction Conditions:

with triethylamine;potassium iodide in ethyl acetate at 25 - 80;

Steps:

XX Preparation of 1-(4-benzyloxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1- yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester

In a clean round bottomed flask ethyl acetate (525ml), ethyl (2Z)-{[4-(benzyloxy)phenyl]hydrazono}(chloro)acetate (35gm), potassium iodide (1.73 g), 3-morpholino-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydropyridin-2(1H)-one (31.82g) and triethylamine (42.63g) were added at about 25-30°C . The reaction mass was heated to about 75-80°C for about 10-15 hrs. After completion, the reaction, mass was cooled to about 0 - 5°C and dilute hydrochloric acid was added slowly to the reaction mass. The temperature of the reaction mass was raised to about 25-30°C and stirred for 5-7 hrs. Ethyl acetate and water were added to the reaction mass and stirred for 15 min. The layers were separated and the organic layer was washed with aq. sodium carbonate solution followed by water and brine solution. The organic layer was concentrated under vacuum and cooled to about 25-30°C. Di isopropyl ether was added to the reaction mass and stirred for 1 hr. The precipitated solid was filtered and washed with di isopropyl ether. The solid was dried under vacuum at 45-50°C for 12hrs to obtain 54gm of 1-(4-benzyloxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1- yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester.

References:

WO2014/111954,2014,A1 Location in patent:Paragraph 0155

Apixaban Impurity 51 Related Search: